 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/304493
Femoro-Popliteal Angioplasty & Stenting - Technology & Market Forecast
|
Description: |
Peripheral Arterial Disease (PAD) of the Femoropopliteal System is a major cause of morbidity and limb loss accounting for over 300,000 amputations in the developed world every year.
Medical therapy is often ineffective and open surgery has substantial risks. Less invasive endovascular approaches has been utilized for several decades in the Femoropopliteal System however, a major limiting factor was late restenosis.
Recent breakthroughs in stent material and design and the introduction of dedicated flexible stents with high radial force that can deliver superior outcome to open surgery promise to rewrite protocols of care and revolutionize the market for Lower Limb Endovascular Revascularization and Repair.
"Femoro-Popliteal Angioplasty & Stenting - Technology & Market Forecast" report gives an overview of the state of both the technology and the market. It profiles the current market landscape and explores the market potential with global forecasts to 2010.
The report draws on the latest findings presented at EuroPCR conference and details many pressing issues in the Fem-Pop Angioplasty & Stenting space including current approved and in-development devices and the status of clinical development of potential new entrants.
Femoro-Popliteal Angioplasty & Stenting - Technology & Market Forecast is your exclusive introduction to top companies and their forward-thinking technologies.
Report Highlights:
- Current state of the science of superficial femoral artery (SFA) angioplasty & stenting.
- Recent clinical trials and their findings. - Epidemiology of PAD, CLI and estimated number of endovascular procedures.
- Current market for fem-pop angioplasty & stenting segmented geographically.
- Potential market for fem-pop angioplasty, stenting, brachytherapy, laser therapy and plaque excision.
- Leading players in the fem-pop angioplasty & stenting space and potential entrants. - Market forecasts to 2010.
Femoro-Popliteal Angioplasty & Stenting - Technology & Market Forecast gives a short but thorough analysis of the global potential market for superficial femoral artery (SFA) endovascular repair. It is targeted at busy executives & venture capitalists scanning for windows of opportunities opening in the peripheral endovascular space.
|
|
Contents: |
1. Executive Summary
2. State of the Science 2.1 Peripheral Artery Disease (PAD) 2.1.1 Epidemiology 2.1.2 Diagnosis 2.1.3 Management 2.2 Interventional Procedures 2.2.1 Angioplasty 2.2.2 Stenting 2.2.3 Other Interventional Modalities 2.3 Surgical Procedures 2.3.1 Bypass Surgery 2.3.2 Endarterectomy 2.3.3 Amputation 2.4 Clinical Trials Update
3. State of the Technology 3.1 Procedure 3.2 Physicians 3.3 Hospitals 3.4 Companies & Products 3.4.1 Boston Scientific 3.4.2 Cook Group 3.4.3 C. R. Bard 3.4.4 Foxhollow Technologies 3.4.5 Johnson & Johnson 3.4.5.1 Cordis 3.4.5.2 Guidant 3.4.6 Other Companies in the Space 3.4.6.1 Abbott 3.4.6.2 AngioDynamics 3.4.6.3 B. Braun 3.4.6.4 CryoVascular Systems 3.4.6.5 Edwards Lifesciences 3.4.6.6 EV3 3.4.6.7 Gore Medical 3.4.6.8 IDev Technologies 3.4.6.9 Medtronic 3.4.6.10 Terumo 3.4.6.11 Vascular Architects
4. Market Forecast 4.1 The Opportunity 4.2 Market Potential 4.3 Market Forecast
|
|
Companies Mentioned |
Boston Scientific, Cook Group, C. R. Bard, Foxhollow Technologies, Johnson & Johnson, Cordis, Guidant, Other Companies in the Space, Abbott, AngioDynamics, B. Braun, CryoVascular Systems, Edwards Lifesciences, EV3, Gore Medical, IDev Technologies, Medtronic, Terumo, Vascular Architects
|
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/304493
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 07/01/2009 21:07:06 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
Femoro-Popliteal Angioplasty & Stenting - Technology & Market Forecast
|
|
Web Address: |
http://www.researchandmarkets.com/reports/304493
|
|
Office Code: |
|
OCIINGLLTOZ
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic
|
|
€480.00
|
|
Electronic
- Site License
|
|
€960.00
|
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353 1 481 1716 or +353 1 653 1571 - From Rest of World
 |
Page 2 of 2 Printed 07/01/2009 21:07:06
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder Name: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353 1 481 1716 or +353 1 653 1571 - From Rest of World
|
 |
 |
|
|